The Journal of Infectious Diseases · 2011 · 26 citations · 36 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityImmunizationVaccinologyAdaptive Immune ResponsesAntigen RecognitionCell-mediated ImmunityImmune Response To VaccinationT Cell ActivationViral VaccinesAntigen-specific Memory ResponsesCd8 Positive T Cell ResponsesCd8 Positive T CellsCellular Immune Response To VirusesInterferon ProductionT Cell Response InductionVaccine-induced Immune MemoryWest Nile Virus Vaccines
ChimeriVax-WN02 is a novel live-attenuated West Nile virus (WNV) vaccine containing modified WNV premembrane (prM) and envelope (E) sequences inserted into the yellow fever 17D vaccine genome. We investigated the induction and evolution of CD8(+) T cell responses to a WNV envelope epitope, which is a dominant target in naturally infected HLA-A*02-positive individuals. WNV epitope-specific CD8(+) T cells were detected by HLA tetramer staining in 22 of 23 donors tested, with peak frequencies occurring between days 14 and 28. WNV epitope-specific T cells evolved from an effector phenotype to a long-lived memory phenotype. In the majority of donors, CD8(+) T cells were able to lyse targets expressing WNV envelope protein and produced macrophage inflammatory protein 1ß, interferon γ, and/or tumor necrosis factor α following envelope peptide stimulation. WNV E-specific CD8(+) T cell responses were detected for up to 1 year after vaccination. The evolution of this WNV-specific T cell response is similar to that observed in established, highly immunogenic vaccines.
36
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Joseph D. Miller, Robbert van der Most, Rama Akondy et al. · Immunity · 2008 · 613 citations · Full text